TGLS 7.12 Updated: 09-24-2017 $TGLS Last Trade:

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
805
TGLS 7.12 Updated: 09-24-2017 $TGLS
Last Trade: 9/22/2017

Last 7.12   - 
Open 7.12
Previous Close 7.12
Day High / Low 7.13 / 7.07
Year High / Low 12.70 / 5.50
Volume 15,625
Projected Volume 15625 (36%)
# of Trades / Projected 43 / 43
Dividend / Yield 0.13 / 1.79%
Abnormal Activity NONE
Abnormal Volume NO
Gap NONE
Candle NEUTRAL
Volatility Today MEDIUM
Volatility Yesterday MEDIUM
Price Relativity
From 40 Day High 76%
From 80 Day High 72%
From 150 Day High 59%
From 40 Day Low 125%
From 80 Day Low 125%
From 150 Day Low 125%
Pivot Analysis
Price Pivot $ 7.11
Day Resistance 1 $ 7.14
Day Support 1 $ 7.08
Day Resistance 2 $ 7.17
Day Support 2 $ 7.05
Consolidations
Short Term YES
Medium Term YES
Long Term YES
Volume Indicators
20 Day Avg Vol 43,461
Today / 20 Day Avg Vol BELOW
150 Day Avg Vol 52,802
Today / 150 Day Avg Vol BELOW
Abnormal Volume NO
William Volume Accumulation bearish
Volume Price Trend bearish
Momentum Indicators
10 Day Trend bullish
40 Day Trend bearish
100 Day Trend bearish
Stochastics neutral
RSI bearish
MACD bearish
Moving Average Indictors
15 Day Trend bullish
45 Day Trend bearish
100 Day Trend bearish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? NONE
Volatility Index Today MEDIUM
Volatility Index Yesterday MEDIUM
10 Day Volatility DECREASING
20 Day Volatility DECREASING
40 Day Volatility DECREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Madrigal Pharmaceuticals Rewards New Employees with Equity Awards

Updated Category News Views 100

Overview of Equity Inducement Awards Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a leading biopharmaceutical organization, has recently initiated equity inducement awards to welcome new talent to its dynamic team. This initiative demonstrates Madrigal's commitment to fostering a strong workforce geared towards tackling significant health challenges related to metabolic...

Continue Reading
Boston Metal Welcomes Roy Harvey to Enhance Board Leadership

Updated Category News Views 202

Boston Metal Appoints Industry Leader Roy Harvey Boston Metal, a prominent technology company that is transforming the landscape of global metals production, has made a significant move by appointing Roy Harvey to its Board of Directors. This decision is pivotal as Boston Metal gears up for the commercial rollout of its groundbreaking Molten Oxide Electrolysis (MOE)...

Continue Reading
RBL LLC Partners with Carnrite Ventures for Biotech Growth

Updated Category News Views 125

RBL LLC Partners with Carnrite Ventures for Biotech Growth RBL LLC, a leading biotech venture creation studio, is excited to announce a significant investment from Carnrite Ventures. This partnership aims to enhance the rapid development of their robust pipeline of innovative therapeutic companies. According to Paul Wotton, the managing partner at RBL, "Carnrite's...

Continue Reading
OncoC4 and AcroImmune Merger: A Milestone in Immunotherapy

Updated Category News Views 106

Introducing the OncoC4 and AcroImmune Merger OncoC4, Inc. has just announced a thrilling merger with AcroImmune, a strategic union that promises to significantly boost OncoC4's standing in the biopharmaceutical sector. This collaboration brings together two companies dedicated to pioneering advancements in cancer treatment, with a special focus on developing unique...

Continue Reading
Rezolve AI Celebrates Major Investment Transforming AI Landscape

Updated Category News Views 92

Rezolve AI Excited About $30 Billion AI Investment Rezolve AI (NASDAQ: RZLV), well-known for its cutting-edge AI-driven commerce solutions, is enthusiastic about the recent announcement from Microsoft and BlackRock. These influential tech companies plan to invest $30 billion into AI infrastructure, a decision that could profoundly alter the landscape of the artificial...

Continue Reading